Haemonetics (HAE) Operating Expenses (2009 - 2026)

Haemonetics has reported Operating Expenses for 18 years, with the latest figure at $145.3 million in Q2 2026.

• On a quarterly basis, Operating Expenses rose 5.04% year-over-year to $145.3 million in Q2 2026; TTM through Jun 2026 was $637.8 million, a 20.27% increase from a year earlier, with the FY2026 full-year figure at $630.9 million, up 19.67% from the prior year.
• Operating Expenses was $145.3 million for Q2 2026 at Haemonetics, down from $221.2 million in the prior quarter.
• The five-year high for Operating Expenses was $221.2 million in Q1 2026, with the low at $102.9 million in Q1 2022.
• Average Operating Expenses over 5 years is $132.1 million, with a median of $134.5 million recorded in 2024.
• The sharpest annual moves came in 2025 and 2026: Operating Expenses slipped 16.61% in 2025, then surged 81.77% in 2026.
• Over 5 years, Operating Expenses stood at $115.4 million in 2022, then gained by 14.26% to $131.9 million in 2023, then rose by 1.99% to $134.5 million in 2024, then advanced by 0.35% to $135.0 million in 2025, then grew by 7.67% to $145.3 million in 2026.
• The last three Operating Expenses figures came in at $145.3 million (Q2 2026), $221.2 million (Q1 2026), and $135.0 million (Q4 2025), per Business Quant data.